171 related articles for article (PubMed ID: 3614813)
1. High-dose metoclopramide and dexamethasone as an antiemetic in outpatients receiving chemotherapy for breast cancer. Second study.
Gez E; Warner-Efraty E; Ben-Yosef R; Ben-Baruch N; Yitzhaki N; Uziely B; Brufman G; Biran S
Oncology; 1987; 44(4):237-9. PubMed ID: 3614813
[TBL] [Abstract][Full Text] [Related]
2. High-dose metoclopramide and dexamethasone as an antiemetic in chemotherapy of breast cancer.
Gez E; Goodman S; Isacson R; Gerra C; Sulkes A
Oncology; 1986; 43(3):173-5. PubMed ID: 3754627
[TBL] [Abstract][Full Text] [Related]
3. Effective control of CMF-related emesis with high-dose dexamethasone: results of a double-blind crossover trial with metoclopramide and placebo.
Pollera CF; Nardi M; Marolla P; Pinnaró P; Terzoli E; Giannarelli D
Am J Clin Oncol; 1989 Dec; 12(6):524-9. PubMed ID: 2589233
[TBL] [Abstract][Full Text] [Related]
4. Ondansetron compared with dexamethasone and metoclopramide as antiemetics in the chemotherapy of breast cancer with cyclophosphamide, methotrexate, and fluorouracil.
Levitt M; Warr D; Yelle L; Rayner HL; Lofters WS; Perrault DJ; Wilson KS; Latreille J; Potvin M; Warner E
N Engl J Med; 1993 Apr; 328(15):1081-4. PubMed ID: 8455665
[TBL] [Abstract][Full Text] [Related]
5. High-dose intravenous metoclopramide versus combination high-dose metoclopramide and intravenous dexamethasone in preventing cisplatin-induced nausea and emesis: a single-blind crossover comparison of antiemetic efficacy.
Strum SB; McDermed JE; Liponi DF
J Clin Oncol; 1985 Feb; 3(2):245-51. PubMed ID: 4038511
[TBL] [Abstract][Full Text] [Related]
6. Combination metoclopramide and dexamethasone: an effective antiemetic regimen in outpatients receiving non-cisplatin chemotherapy.
Strum SB; McDermed JE; Streng BR; McDermott NM
J Clin Oncol; 1984 Sep; 2(9):1057-63. PubMed ID: 6470755
[TBL] [Abstract][Full Text] [Related]
7. Tropisetron (Navoban) alone and in combination with dexamethasone in the prevention of chemotherapy-induced emesis: the Nordic experience.
Sorbe BG
Semin Oncol; 1994 Oct; 21(5 Suppl 9):20-6. PubMed ID: 9113123
[TBL] [Abstract][Full Text] [Related]
8. Chlorpromazine and dexamethasone versus high-dose metoclopramide and dexamethasone in patients receiving cancer chemotherapy, particularly cis-platinum: a prospective randomized crossover study.
Gez E; Ben-Yosef R; Catane R; Brufman G; Biran S
Oncology; 1989; 46(3):150-4. PubMed ID: 2654792
[TBL] [Abstract][Full Text] [Related]
9. Comparison of ondansetron with metoclopramide in prevention of acute emesis associated with low dose & high dose cisplatin chemotherapy.
Bhatia A; Tripathi KD; Sharma M
Indian J Med Res; 2003 Jul; 118():33-41. PubMed ID: 14748464
[TBL] [Abstract][Full Text] [Related]
10. An audit of antiemetic use with CMF chemotherapy.
Brown RS; Brown TK; Hoare D; Gaze MN
Clin Oncol (R Coll Radiol); 1998; 10(5):313-7. PubMed ID: 9848332
[TBL] [Abstract][Full Text] [Related]
11. Antiemetic efficacy of high-dose metoclopramide and dexamethasone in patients receiving cisplatin chemotherapy: a randomized trial.
Tsavaris N; Tsaroucha-Noutsou E; Bacoyannis C; Mylonakis N; Valilis P; Kozatsani-Halividi D; Tsoutsos H; Droufakou S; Kosmidis P
Oncology; 1992; 49(6):479-83. PubMed ID: 1465288
[TBL] [Abstract][Full Text] [Related]
12. Antiemetic efficacy of high-dose intravenous metoclopramide and dexamethasone in patients receiving cisplatin-based chemotherapy: a randomized controlled trial.
Shinkai T; Saijo N; Eguchi K; Sasaki Y; Tamura T; Tominaga K; Sakurai M; Sano T; Taito H; Takahashi H
Jpn J Clin Oncol; 1986 Sep; 16(3):279-87. PubMed ID: 3534348
[TBL] [Abstract][Full Text] [Related]
13. Double-blind crossover study of the antiemetic efficacy of high-dose dexamethasone versus high-dose metoclopramide.
Aapro MS; Plezia PM; Alberts DS; Graham V; Jones SE; Surwit EA; Moon TE
J Clin Oncol; 1984 May; 2(5):466-71. PubMed ID: 6539363
[TBL] [Abstract][Full Text] [Related]
14. Ondansetron + dexamethasone vs metoclopramide + dexamethasone + diphenhydramine in prevention of cisplatin-induced emesis. Italian Group For Antiemetic Research.
Lancet; 1992 Jul; 340(8811):96-9. PubMed ID: 1352024
[TBL] [Abstract][Full Text] [Related]
15. The antiemetic efficacy of methylprednisolone compared with metoclopramide in outpatients receiving adjuvant CMF chemotherapy for breast cancer: a randomized trial.
Campora E; Chiara S; Bruzzi P; Scarsi P; Rosso R
Tumori; 1985 Oct; 71(5):459-62. PubMed ID: 3904102
[TBL] [Abstract][Full Text] [Related]
16. Antiemetic efficacy of nabilone and dexamethasone: a randomized study of patients with lung cancer receiving chemotherapy.
Niiranen A; Mattson K
Am J Clin Oncol; 1987 Aug; 10(4):325-9. PubMed ID: 3039831
[TBL] [Abstract][Full Text] [Related]
17. Oral combination antiemetics in patients with small cell lung cancer receiving cisplatin or cyclophosphamide plus doxorubicin.
Cleri LB; Kris MG; Tyson LB; Pisters KM; Clark RA; Gralla RJ
Cancer; 1995 Sep; 76(5):774-8. PubMed ID: 8625179
[TBL] [Abstract][Full Text] [Related]
18. [Improved control of cisplatin-induced emesis with high-dose metoclopramide, dexamethasone and lorazepam].
Mau YK; Li YT; Tsui MS; Tu FC; Hsu KP
Zhonghua Yi Xue Za Zhi (Taipei); 1991 Feb; 47(2):116-20. PubMed ID: 1848133
[TBL] [Abstract][Full Text] [Related]
19. [The prevention of CDDP-induced emesis with a combination regimen including metoclopramide, dexamethasone, droperidol and diphenhydramine].
Dozono H; Yasuda M; Yokoyama S; Takahashi S; Ochiai K; Tsuruoka M; Morimoto O; Sasaki H; Arihiro T; Terashima Y
Nihon Sanka Fujinka Gakkai Zasshi; 1987 Nov; 39(11):1968-72. PubMed ID: 3429979
[TBL] [Abstract][Full Text] [Related]
20. Chemotherapy-induced emesis: management of early and delayed emesis in milder emetogenic regimens.
Barrenetxea G; Schneider J; Centeno MM; Romero H; de la Rica M; RodrÃguez-Escudero FJ
Cancer Chemother Pharmacol; 1996; 38(5):471-5. PubMed ID: 8765442
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]